Evaluation of tumor MET protein expression, MET gene amplification, and HER2 expression in Chinese p

来源 :第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 | 被引量 : 0次 | 上传用户:lllljx
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective: Gastric cancer is a disease with high unmet medical needs in China.MET and its ligand, hepatocyte growth factor, are potential targets in G/GEJ cancer.
其他文献
Objective: To investigate the association of the genetic polymorphisms in HEEX gene, a DM promoting hereditary factor, and the susceptibility and progression of CRC.
会议
Objective: Patients were excluded if they were older than 75 years of age in most clinical trials.Thus, the optimal treatment strategies in elderly patients are still controversial.
Objective: Our previous study indicated that a preoperative CTC≥2 was an independent prognosticator for early recurrence in hepatocellular carcinoma (HCC).Recurrent foci developed in these patients we
Objective: This phase Ⅰ/Ⅱ trial aimed to determine the maximum tolerated dose (MTD) and toxicity profile of S-1 with concomitant intensity modulated radiotherapy (IMRT) as an adjuvant treatment for lo
Objective: Microvessel density (MVD) as an angiogenesis predictor is inefficient per se in cancer prognosis.We evaluated prognostic values of combining intratumoral alpha-smooth muscle actin (α-SMA)-p
Objective: Loss of DCP4 plays a key role in the development of colorectal cancer.Recent studies demonstrated that ectopically expressed miRNAs is another important factor which lead to DCP4 inactivati
Objective: Our aim was to determine impact of negative to positive lymph node ratio (NPR) on oncological outcomes in a series of patients with stage Ⅲ colorectal cancer.
Objective: To analyze the outcome, as well as the prognostic factors in thoracic esophageal squamous cell carcinoma patients who received the IMRT-based neoadjuvant chemoradiotherapy followed by surge
目的:转移导致乳腺癌患者死亡的首要因素,血行转移是肿瘤转移的最重要的方式之一。以往研究显示,在肿瘤血行转移过程中,血小板可粘附于肿瘤细胞表面,保护肿瘤细胞免受血流的机械损伤和免疫攻击,并协助肿瘤细胞在远隔部位定植。
Objective: To evaluate the maximum tolerated dose (MTD) of concurrent capecitabine with preoperative radiation (RT) in elderly patients with rectal cancer, as well as safety and efficacy.